BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26546523)

  • 1. Influence of Palmatine on Bone Metabolism in Ovariectomized Mice and Cytokine Secretion of Osteoblasts.
    Ishikawa S; Ogawa Y; Tamaki M; Takashima M; Tajika Y; Moue T; Zhang M; Kusayanagi H; Sunagawa M; Hisamitsu T
    In Vivo; 2015; 29(6):671-7. PubMed ID: 26546523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opg/Rankl mRNA dynamic expression in the bone tissue of ovariectomized rats with osteoporosis.
    Li CW; Liang B; Shi XL; Wang H
    Genet Mol Res; 2015 Aug; 14(3):9215-24. PubMed ID: 26345854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats.
    Mai QG; Zhang ZM; Xu S; Lu M; Zhou RP; Zhao L; Jia CH; Wen ZH; Jin DD; Bai XC
    J Cell Biochem; 2011 Oct; 112(10):2902-9. PubMed ID: 21618594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palmatine attenuates osteoclast differentiation and function through inhibition of receptor activator of nuclear factor-κb ligand expression in osteoblast cells.
    Lee JW; Mase N; Yonezawa T; Seo HJ; Jeon WB; Cha BY; Nagai K; Woo JT
    Biol Pharm Bull; 2010; 33(10):1733-9. PubMed ID: 20930384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
    Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
    Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of IL-7 is increased in ovariectomized mice, but not RANKL mRNA expression by osteoblasts/stromal cells in bone, and IL-7 enhances generation of osteoclast precursors in vitro.
    Sato T; Watanabe K; Masuhara M; Hada N; Hakeda Y
    J Bone Miner Metab; 2007; 25(1):19-27. PubMed ID: 17187190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones.
    Ikeda T; Utsuyama M; Hirokawa K
    J Bone Miner Res; 2001 Aug; 16(8):1416-25. PubMed ID: 11499864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Puerarin prevents bone loss in ovariectomized mice and inhibits osteoclast formation in vitro.
    Yuan SY; Sheng T; Liu LQ; Zhang YL; Liu XM; Ma T; Zheng H; Yan Y; Ishimi Y; Wang XX
    Chin J Nat Med; 2016 Apr; 14(4):265-269. PubMed ID: 27114313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-osteoporotic activity of puerarin 6"-O-xyloside on ovariectomized mice and its potential mechanism.
    Li H; Chen B; Pang G; Chen J; Xie J; Huang H
    Pharm Biol; 2016; 54(1):111-7. PubMed ID: 25857587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in osteoblasts.
    Takami M; Takahashi N; Udagawa N; Miyaura C; Suda K; Woo JT; Martin TJ; Nagai K; Suda T
    Endocrinology; 2000 Dec; 141(12):4711-9. PubMed ID: 11108286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin alleviates glucocorticoid-induced osteoporosis through the regulation of the Wnt signaling pathway.
    Chen Z; Xue J; Shen T; Mu S; Fu Q
    Int J Mol Med; 2016 Feb; 37(2):329-38. PubMed ID: 26677102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calycosin attenuates osteoporosis and regulates the expression of OPG/RANKL in ovariectomized rats
    Li N; Tu Y; Shen Y; Qin Y; Lei C; Liu X
    Pharmazie; 2016 Oct; 71(10):607-612. PubMed ID: 29441931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of estrogen on osteoprotegerin, osteoclast differentiation factor and macrophage colony stimulating factor mRNA expressions in ovariectomized rat bone tissue].
    Wang Q; Wang KZ; Dang XQ; Shi ZB; Pei XW; Bai CY; Jia XW
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Apr; 26(4):532-4. PubMed ID: 16624776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific antigen stimulates osteoprotegerin production and inhibits receptor activator of nuclear factor-kappaB ligand expression by human osteoblasts.
    Yonou H; Horiguchi Y; Ohno Y; Namiki K; Yoshioka K; Ohori M; Hatano T; Tachibana M
    Prostate; 2007 Jun; 67(8):840-8. PubMed ID: 17394194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine alleviates oxidative stress in rats with osteoporosis through receptor activator of NF-kB/receptor activator of NF-kB ligand/osteoprotegerin (RANK/RANKL/OPG) pathway.
    He XF; Zhang L; Zhang CH; Zhao CR; Li H; Zhang LF; Tian GF; Guo MF; Dai Z; Sui FG
    Bosn J Basic Med Sci; 2017 Nov; 17(4):295-301. PubMed ID: 29055350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salidroside Improves Bone Histomorphology and Prevents Bone Loss in Ovariectomized Diabetic Rats by Upregulating the OPG/RANKL Ratio.
    Zheng H; Qi S; Chen C
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30235836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system.
    Liu XH; Kirschenbaum A; Yao S; Levine AC
    Endocrinology; 2005 Apr; 146(4):1991-8. PubMed ID: 15618359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of arachidonic acid, docosahexaenoic acid, prostaglandin E(2) and parathyroid hormone on osteoprotegerin and RANKL secretion by MC3T3-E1 osteoblast-like cells.
    Coetzee M; Haag M; Kruger MC
    J Nutr Biochem; 2007 Jan; 18(1):54-63. PubMed ID: 16650751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoblasts provide a suitable microenvironment for the action of receptor activator of nuclear factor-kappaB ligand.
    Yamamoto Y; Udagawa N; Matsuura S; Nakamichi Y; Horiuchi H; Hosoya A; Nakamura M; Ozawa H; Takaoka K; Penninger JM; Noguchi T; Takahashi N
    Endocrinology; 2006 Jul; 147(7):3366-74. PubMed ID: 16627581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver X receptors orchestrate osteoblast/osteoclast crosstalk and counteract pathologic bone loss.
    Kleyer A; Scholtysek C; Bottesch E; Hillienhof U; Beyer C; Distler JH; Tuckermann JP; Schett G; Krönke G
    J Bone Miner Res; 2012 Dec; 27(12):2442-51. PubMed ID: 22806960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.